SkinBioTherapeutics PLC (AIM: SBTX) shares rose sharply after a regulatory filing revealed a major increase in ownership by investors Mark H Dixon and Diana Dixon.
SkinBioTherapeutics plc shares plunges over 40% after “alarming” investor update
SkinBioTherapeutics (AIM: SBTX), shares plunged more than 40% on Monday, extending losses after a 50% fall on Friday, following what the company described as an alarming update to investors.
SkinBioTherapeutics shares sink 30% on CEO departure and management reshuffle
SkinBioTherapeutics plc (AIM: SBTX), shares fell around 30% after the skin health-focused life sciences company announced the resignation of its chief executive officer, Stuart Ashman.
SkinBioTherapeutics Confirms WRAP Retail Offer Results, Completing £4.2m Fundraise
SkinBioTherapeutics plc (AIM: SBTX), a life science group focused on skin health, has confirmed the final results of its WRAP Retail Offer, completing a broader £4.2 million fundraising effort at
SkinBioTherapeutics (AIM:SBTX) Superdrug agreement, Placing & Retail Offer
SkinBioTherapeutics signs exclusive commercial agreement with Superdrug for AxisBiotix™ products in the UK Placing and Subscription to raise £4.1m to support Superdrug agreement; Proposed Retail Offer to existing shareholders of
SkinBioTherapeutics (AIM: SBTX) Acquisition and Financial Update
Acquisition of Bio-Tech Solutions Ltd and Financial Update